These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3258505)

  • 1. Renal impairment in relation to non-steroidal anti-inflammatory drugs.
    Dixon JS; Bojar R; Bird HA
    Ann Rheum Dis; 1988 Mar; 47(3):260. PubMed ID: 3258505
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency.
    Brooks PM; McCredie M; Prowse M; Podgorski M; Forrest M; Munro I; Boutagy J; Pei-Ling L
    Pharmatherapeutica; 1986; 4(10):665-72. PubMed ID: 3602018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tenoxicam and renal function. Short-term and long-term prospective studies].
    Giovannoni JL; Ott H; de Torrenté A
    Schweiz Med Wochenschr; 1990 May; 120(21):793-7. PubMed ID: 2349462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hepatitis caused by tenoxicam.
    Sungur C; Ates B; Akbas O
    Ann Pharmacother; 1994 Nov; 28(11):1309. PubMed ID: 7849359
    [No Abstract]   [Full Text] [Related]  

  • 5. Tenoxicam and renal function.
    Heintz RC
    Drug Saf; 1995 Feb; 12(2):110-9. PubMed ID: 7766336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypoglycemia secondary to tenoxicam].
    Moreno M; Ruíz Ruiz D; Ramos Barrantes I; Martín Arias LH; Carvajal García-Pando A
    Rev Clin Esp; 1992 Jun; 191(1):50-1. PubMed ID: 1631364
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastric inflammatory polyposis after long-term intermittent use of nonsteroidal anti-inflammatory drugs and histamine2-receptor antagonists.
    Hizawa K; Takeya T; Yao T; Yamamoto H; Aomi H; Nakahara T; Matsumoto T; Iida M
    Endoscopy; 2005 Jul; 37(7):685. PubMed ID: 16010622
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stevens-Johnson syndrome caused by isoxicam].
    Capizzi R; Cacciaguerra MG; Guerriero G; Tulli A
    G Ital Dermatol Venereol; 1986; 121(6):461-2. PubMed ID: 3557542
    [No Abstract]   [Full Text] [Related]  

  • 9. Tenoxicam, a new non-steroidal anti-inflammatory drug in the prolonged treatment of rheumatoid arthritis.
    Gentiletti AA
    Eur J Rheumatol Inflamm; 1987; 9(2):91-4. PubMed ID: 3329116
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oxicam hypersensitivity syndrome].
    Baudot S; Milpied-Homsi B; Jumbo O; Larousse C
    Therapie; 1998; 53(6):595-6. PubMed ID: 10070240
    [No Abstract]   [Full Text] [Related]  

  • 11. Photoclinic. Fixed drug eruption.
    Santos VM; Santos SC; Almeida AC; Sugai TA
    Arch Iran Med; 2011 Jan; 14(1):71-2. PubMed ID: 21194268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alopecia secondary to tenoxicam. An undescribed adverse effect?].
    Aroca García MD; Luna Rodríguez C; Gallego Navarro MA; Ortiz de Solar E
    Aten Primaria; 1997; 20(3):157. PubMed ID: 9303679
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tenoxicam].
    Friis J
    Ugeskr Laeger; 1988 Oct; 150(42):2542. PubMed ID: 3264638
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cholestatic hepatitis associated with tenoxicam].
    Pascual AF; Jiménez Martos F; Rodríguez Moreno C
    Aten Primaria; 1995 Mar; 15(5):329. PubMed ID: 7734692
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-induced aphthae].
    Vincent L; Frappaz A; Cousin F; Sauret V; Pacheco Y; Nicolas JF
    Ann Dermatol Venereol; 2001 Jan; 128(1):57. PubMed ID: 11291642
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe toxic dermatitis caused by tenoxicam (Tilcotil). 3 cases].
    Chosidow O; Lebre C; Roujeau JC; Revuz J
    Ann Dermatol Venereol; 1991; 118(11):903-4. PubMed ID: 1838675
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-steroidal antiinflammatory agents in therapy of postoperative pain].
    Maiachkin RB; Nikoda VV
    Anesteziol Reanimatol; 2002; (6):73-8. PubMed ID: 12611166
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind, parallel clinical trial of tenoxicam (Ro 12-0068) versus piroxicam in patients with ankylosing spondylitis.
    Astorga G
    Eur J Rheumatol Inflamm; 1987; 9(2):70-3. PubMed ID: 3329111
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis.
    Havranek H
    Eur J Rheumatol Inflamm; 1987; 9(2):105-8. PubMed ID: 3329099
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tenoxicam-induced agranulocytosis, with good response to colony stimulating factor (G-CSF)].
    Sánchez Sevillano A; Blázquez Encinar JC; Femenia Pérez M; Mora Rufete MA
    An Med Interna; 1993 Oct; 10(10):519-20. PubMed ID: 7511003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.